---
title: "Regulatory Update: Turkey"
description: Regulatory Update for Turkey, October 2023.
image: https://blog.arazygroup.com/hubfs/imgpsh_fullsize_anim-Oct-16-2023-05-39-41-6015-PM.jpg
---

Open main menu Close main menu

- [Join The Regulatory Rockstar Movement](https://info.arazygroup.com/regulatory_rockstar_movement)

[Regulatory Update](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-update)

# Regulatory Update: Turkey

[Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group)

[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-turkey-1) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-turkey-1) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-turkey-1)

![](https://blog.arazygroup.com/hubfs/imgpsh_fullsize_anim-Oct-16-2023-05-39-41-6015-PM.jpg)

On September 15, 2023, an important Update on Regulatory Repeal and Evaluation in Turkey was published. This update, referenced as Announcement of Repeal No. 2023/KK-4, marks the repeal of the prior Interim Announcement No. 2021/KK-4. This change has come into effect in response to recent developments, specifically, the World Health Organization (WHO) declaration on May 5, 2023, signaling the end of the “global pandemic.”

It is important to note two key changes:

1. Effective September 15, 2023, no time extensions will be granted for documents requiring physical or nonphysical applications that have not undergone the apostille or embassy/consulate approval procedures within the framework of the provisions in Announcement No. 2021/KK-4.
2. Starting September 15, 2023, all document applications will be exclusively evaluated within the context of the provisions stipulated in Announcement No. 2022/KK-1.

For the full resource, visit [here](https://www.titck.gov.tr/duyuru/2023-kk-4-sayili-2021-kk-4-sayili-gecici-duyuruyu-yururlukten-kaldiran-duyuru-22062023011155). Only available in Turkish. 

 

Subscribe for regulatory updates to always keep up with evolving guidelines! 

## Related Articles

[![](https://blog.arazygroup.com/hubfs/iStock-1394397658.jpg)](https://blog.arazygroup.com/regulatory-affairs-advance/market-access-readiness-simplified)

[Regulatory Affairs](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-affairs) [Medtech](https://blog.arazygroup.com/regulatory-affairs-advance/tag/medtech)

### [Market Access Readiness - Simplified!](https://blog.arazygroup.com/regulatory-affairs-advance/market-access-readiness-simplified)

Based on their current documentation, are you curious about how ready your medical and IVD devices are to enter new markets? Look no further than MARI%™ – the Market...

[Benjamin Arazy](https://blog.arazygroup.com/regulatory-affairs-advance/author/benjamin-arazy) 

[Read More](https://blog.arazygroup.com/regulatory-affairs-advance/market-access-readiness-simplified)

[![](https://blog.arazygroup.com/hubfs/iStock-1448474068-1.jpg)](https://blog.arazygroup.com/regulatory-affairs-advance/clinical-evaluation-reports)

[Regulatory Affairs](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-affairs) [Clinical Evalutation](https://blog.arazygroup.com/regulatory-affairs-advance/tag/clinical-evalutation)

### [Clinical Evaluation Reports](https://blog.arazygroup.com/regulatory-affairs-advance/clinical-evaluation-reports)

Clinical evaluation of a medical device aims to show that the device offers more benefits and poses less risk than state-of-the-art treatments or is at least comparable...

[Diana Gavrilov Negev](https://blog.arazygroup.com/regulatory-affairs-advance/author/diana-gavrilov-negev) 

[Read More](https://blog.arazygroup.com/regulatory-affairs-advance/clinical-evaluation-reports)

[Follow us on Facebook](https://www.facebook.com/Arazygroup/) [Follow us on LinkedIn](https://www.linkedin.com/company/arazy-group) [Follow us on Instagram](https://www.instagram.com/arazy_group/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Arazy Group",
    "url" : "https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group"
  },
  "dateModified" : "2024-06-21T18:49:16.147Z",
  "datePublished" : "2023-10-16T17:40:50.000Z",
  "headline" : "Regulatory Update: Turkey",
  "image" : [ "https://blog.arazygroup.com/hubfs/imgpsh_fullsize_anim-Oct-16-2023-05-39-41-6015-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-turkey-1",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.arazygroup.com/hubfs/Arazy%20Group%20Logos%201.png"
    },
    "name" : "Arazy Group Consultants Inc."
  }
}
```